patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Bid and ask are .24 apart

At first I thought they were having problems pricing the stock because it was new to the NAZ.  The volume is extremely low but the SP swings are wild.  I thought for sure that they would have something to announce right away.  To come on the NAZ with no income and no big announcement is suicide for a biotech company - Pluristem should know this.  The news could/should be coming soon.  It sounds like they may not even want to sell the company to a biotech giant because they really think they have something. 

We may have to have Emma give Frank a call soon ; )

Share
New Message
Please login to post a reply